PRL and sexual dysfunction: The primary outcome is the overall prevalence of sexual dysfunction among patients undergoing antipsychotic treatment, while the secondary outcomes include the domains of sexual dysfunction (e.g., desire, arousal, orgasm) and serum prolactin levels.